| abstract |
The present invention relates to a compound of formula (I): [Chemical 1] And the pharmaceutically acceptable salts or tautomers thereof, which are inhibitors of poly (ADP-ribose) polymerase (PARP) and are therefore cancer, inflammatory disease, reperfusion injury, false Serum, stroke, renal failure, cardiovascular disease, non-cardiovascular disease, diabetes, neurodegenerative disease, retroviral infection, retinal damage, skin aging, and UV-induced skin damage, and cancer treatment It is useful as a chemical sensitizer or a radio sensitizer for use. |